7-5987566-T-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000535.7(PMS2):āc.1199A>Cā(p.Gln400Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000676 in 1,613,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PMS2 | NM_000535.7 | c.1199A>C | p.Gln400Pro | missense_variant | 11/15 | ENST00000265849.12 | NP_000526.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PMS2 | ENST00000265849.12 | c.1199A>C | p.Gln400Pro | missense_variant | 11/15 | 1 | NM_000535.7 | ENSP00000265849.7 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152150Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000763 AC: 19AN: 249052Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135312
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1460944Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726820
GnomAD4 genome AF: 0.000420 AC: 64AN: 152268Hom.: 0 Cov.: 31 AF XY: 0.000524 AC XY: 39AN XY: 74446
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Nov 06, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Sep 23, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Observed in an individual with early-onset colorectal cancer whose tumor demonstrated normal expression of mismatch repair proteins on immunohistochemistry (Pearlman 2017); This variant is associated with the following publications: (PMID: 22675565, 29596542, 27978560) - |
Likely benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Apr 08, 2020 | - - |
PMS2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 07, 2023 | The PMS2 c.1199A>C variant is predicted to result in the amino acid substitution p.Gln400Pro. This variant has been reported in an individual with with early-onset colorectal cancer with normal mismatch repair protein expression in the tumor on imunohistochemisty (eTable 2, Pearlman et al. 2017. PubMed ID: 27978560). It has also been reported in an individual with T-cell acute lymphoblastic leukemia (Table S3, Atak et al. 2012. PubMed ID: 22675565). In the gnomAD public population database this variant has been reported in up to 0.1 % of alleles in an African subpopulation (http://gnomad.broadinstitute.org/variant/7-6027197-T-G). However, this variant occurs in a highly paralogous region and allele frequency data should be interpreted with caution. This variant has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from benign to a variant of uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/142625/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 05, 2023 | - - |
Hereditary nonpolyposis colorectal neoplasms Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at